Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója

Translated title of the contribution: Percutaneous closure of patent foramen ovale, as secundaer prevention of cryptogen ischemic stroke

András Temesvári, Olga Hajnalka Bálint, Csilla Liptai, Sándor Kancz, Balázs Németh, A. Szatmári

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In patients with patent foramen ovale and cryptogenic stroke, the risk of recurrent event is about 4-5% yearly, despite of the antithrombotic treatment. Transcatheter closure of patent foramen ovale has been shown to decrease risk of recurrence. This report summarizes the first experiences in Hungary and the medium term follow up of our patients. Thirty-three patients were selected for closure. All the patients had at least one ischemic stroke, transitory ischemic attack or peripheral embolus. In 31 of them the stroke was confirmed by computer tomographic or magnetic resonance imaging. Patent foramen ovale with right-to-left shunt was diagnosed by transesophageal echocardiography. Transcatheter closure was performed under fluoroscopic and transesophageal echocardiographic control. Closure was successful in 31 patients. Passage of atrial septum did not succeed in two cases. An AV fistula at puncture site was the only early complication. There was no late complication. No device dislocation, periprocedural arrhythmia or embolic event was detected. No residual shunt could be found. During follow up of 11.3 (1-30) months no recurrent embolus was detected. Transcatheter closure of patent foramen ovale is a safe and efficient procedure to decrease the risk of recurrent ischemic events.

Original languageHungarian
Pages (from-to)2035-2039
Number of pages5
JournalOrvosi Hetilap
Volume147
Issue number42
Publication statusPublished - Oct 22 2006

Fingerprint

Patent Foramen Ovale
Stroke
Embolism
Atrial Septum
Hungary
Transesophageal Echocardiography
Punctures
Fistula
Cardiac Arrhythmias
Magnetic Resonance Imaging
Recurrence
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Temesvári, A., Bálint, O. H., Liptai, C., Kancz, S., Németh, B., & Szatmári, A. (2006). Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója. Orvosi Hetilap, 147(42), 2035-2039.

Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója. / Temesvári, András; Bálint, Olga Hajnalka; Liptai, Csilla; Kancz, Sándor; Németh, Balázs; Szatmári, A.

In: Orvosi Hetilap, Vol. 147, No. 42, 22.10.2006, p. 2035-2039.

Research output: Contribution to journalArticle

Temesvári, A, Bálint, OH, Liptai, C, Kancz, S, Németh, B & Szatmári, A 2006, 'Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója', Orvosi Hetilap, vol. 147, no. 42, pp. 2035-2039.
Temesvári A, Bálint OH, Liptai C, Kancz S, Németh B, Szatmári A. Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója. Orvosi Hetilap. 2006 Oct 22;147(42):2035-2039.
Temesvári, András ; Bálint, Olga Hajnalka ; Liptai, Csilla ; Kancz, Sándor ; Németh, Balázs ; Szatmári, A. / Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója. In: Orvosi Hetilap. 2006 ; Vol. 147, No. 42. pp. 2035-2039.
@article{b1e3e0a40c2f46cda5cd89a90f60630f,
title = "Nyitott foramen ovale kat{\'e}teres z{\'a}r{\'a}sa, a cryptogen agyi t{\"o}rt{\'e}n{\'e}s szekunder prevenci{\'o}ja",
abstract = "In patients with patent foramen ovale and cryptogenic stroke, the risk of recurrent event is about 4-5{\%} yearly, despite of the antithrombotic treatment. Transcatheter closure of patent foramen ovale has been shown to decrease risk of recurrence. This report summarizes the first experiences in Hungary and the medium term follow up of our patients. Thirty-three patients were selected for closure. All the patients had at least one ischemic stroke, transitory ischemic attack or peripheral embolus. In 31 of them the stroke was confirmed by computer tomographic or magnetic resonance imaging. Patent foramen ovale with right-to-left shunt was diagnosed by transesophageal echocardiography. Transcatheter closure was performed under fluoroscopic and transesophageal echocardiographic control. Closure was successful in 31 patients. Passage of atrial septum did not succeed in two cases. An AV fistula at puncture site was the only early complication. There was no late complication. No device dislocation, periprocedural arrhythmia or embolic event was detected. No residual shunt could be found. During follow up of 11.3 (1-30) months no recurrent embolus was detected. Transcatheter closure of patent foramen ovale is a safe and efficient procedure to decrease the risk of recurrent ischemic events.",
keywords = "Cryptogenic stroke, Patent foramen ovale, Transcatheter closure",
author = "Andr{\'a}s Temesv{\'a}ri and B{\'a}lint, {Olga Hajnalka} and Csilla Liptai and S{\'a}ndor Kancz and Bal{\'a}zs N{\'e}meth and A. Szatm{\'a}ri",
year = "2006",
month = "10",
day = "22",
language = "Hungarian",
volume = "147",
pages = "2035--2039",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "42",

}

TY - JOUR

T1 - Nyitott foramen ovale katéteres zárása, a cryptogen agyi történés szekunder prevenciója

AU - Temesvári, András

AU - Bálint, Olga Hajnalka

AU - Liptai, Csilla

AU - Kancz, Sándor

AU - Németh, Balázs

AU - Szatmári, A.

PY - 2006/10/22

Y1 - 2006/10/22

N2 - In patients with patent foramen ovale and cryptogenic stroke, the risk of recurrent event is about 4-5% yearly, despite of the antithrombotic treatment. Transcatheter closure of patent foramen ovale has been shown to decrease risk of recurrence. This report summarizes the first experiences in Hungary and the medium term follow up of our patients. Thirty-three patients were selected for closure. All the patients had at least one ischemic stroke, transitory ischemic attack or peripheral embolus. In 31 of them the stroke was confirmed by computer tomographic or magnetic resonance imaging. Patent foramen ovale with right-to-left shunt was diagnosed by transesophageal echocardiography. Transcatheter closure was performed under fluoroscopic and transesophageal echocardiographic control. Closure was successful in 31 patients. Passage of atrial septum did not succeed in two cases. An AV fistula at puncture site was the only early complication. There was no late complication. No device dislocation, periprocedural arrhythmia or embolic event was detected. No residual shunt could be found. During follow up of 11.3 (1-30) months no recurrent embolus was detected. Transcatheter closure of patent foramen ovale is a safe and efficient procedure to decrease the risk of recurrent ischemic events.

AB - In patients with patent foramen ovale and cryptogenic stroke, the risk of recurrent event is about 4-5% yearly, despite of the antithrombotic treatment. Transcatheter closure of patent foramen ovale has been shown to decrease risk of recurrence. This report summarizes the first experiences in Hungary and the medium term follow up of our patients. Thirty-three patients were selected for closure. All the patients had at least one ischemic stroke, transitory ischemic attack or peripheral embolus. In 31 of them the stroke was confirmed by computer tomographic or magnetic resonance imaging. Patent foramen ovale with right-to-left shunt was diagnosed by transesophageal echocardiography. Transcatheter closure was performed under fluoroscopic and transesophageal echocardiographic control. Closure was successful in 31 patients. Passage of atrial septum did not succeed in two cases. An AV fistula at puncture site was the only early complication. There was no late complication. No device dislocation, periprocedural arrhythmia or embolic event was detected. No residual shunt could be found. During follow up of 11.3 (1-30) months no recurrent embolus was detected. Transcatheter closure of patent foramen ovale is a safe and efficient procedure to decrease the risk of recurrent ischemic events.

KW - Cryptogenic stroke

KW - Patent foramen ovale

KW - Transcatheter closure

UR - http://www.scopus.com/inward/record.url?scp=34748892937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748892937&partnerID=8YFLogxK

M3 - Article

C2 - 17165604

AN - SCOPUS:34748892937

VL - 147

SP - 2035

EP - 2039

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 42

ER -